GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Noxopharm NOX.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.04

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Noxopharm — daily ASX:NOX

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Noxopharm on TradingView ↗
Market value
A$10.2m
Last close × shares
Volume
13.5k
Shares, 9 Nov 2026

About Noxopharm

Its shares trade on ASX under the ticker NOX.AX. It has been listed since 9 August 2016. In the fiscal year to 30 June 2026, it reported revenue of A$1.4m and a net loss of A$4.5m. At that date it held total assets of A$1.8m and shareholders' equity of −A$3.6m.

Noxopharm Ltd. engages in the research and development of drugs. The company is headquartered in Castle Hill, New South Wales. The company went IPO on 2016-08-09. The firm is engaged in the discovery and development of treatments for cancer and inflammation. The firm has three active drug development programs: its clinical drug candidate Veyonda, plus two technology platforms, Chroma (oncology) and Sofra (inflammation and autoimmunity), which provide the basis for the active development of a growing pipeline of drugs. Veyonda (Idronoxil) is an adjuvant therapy in chemotherapy and radiotherapy in the treatment of late-stage cancers. The Chroma drug candidates have bioactive properties, which it is exploring primarily in the anti-cancer space. Its Sofra platform is centered around short nucleic acid sequences called oligonucleotides, which can act on specific cell receptors to stop inflammation, which is a source of various debilitating and lethal diseases. The company is also conducting a dose escalation and dose expansion study of NOX66 in the treatment of COVID-19 infection.

Figures and description from our data supplier, not checked against the company's own report.

More about Noxopharm →

Latest on Noxopharm

Our reporting

We have not reported on Noxopharm yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Noxopharm's ticker?

Noxopharm trades as NOX.AX on ASX, under ISIN AU000000NOX9.

What was Noxopharm's last closing price?

0.04 on 9 Nov 2026. The figure is in AUD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.